Martin A. Lehr - 13 Feb 2023 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Executive Officer, Director
Signature
Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
13 Feb 2023
Net transactions value
$0
Form type
4
Filing time
14 Feb 2023, 16:04:39 UTC
Previous filing
06 Feb 2023
Next filing
21 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +287,544 $0.000000 287,544 13 Feb 2023 Common Stock 287,544 $0.8407 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.